Blueprint Medicines (BPMC) Tops Q1 EPS by 14c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Blueprint Medicines Reports First Quarter 2021 Financial Results
April 29, 2021 7:00 AM EDTCAMBRIDGE, Mass., April 29, 2021 /PRNewswire/ --Â Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the first quarter ended March 31, 2021.
"In recent months, we made significant progress toward achieving our key 2021 portfolio goals, illustrating our clinical... More
